Brazil’s intervention at Special Session of the Executive Board on WHO Reform
The following is the intervention delivered by Brazil on 1 November 2011 at the Special Session of the Executive Board on WHO Reform.
INTERVENCÃO DA EMBAIXADORA MARIA NAZARETH FARANI AZEVÊDO NA ABERTURA DA SESSÃO
ESPECIAL DO CONSELHO EXECUTIVO DA OMS SOBRE A REFORMA DA ORGANIZACÃOGenebra, 1º de novembro de 2011
Mr. Chairman,
WTO TRIPS Council: Ecuador questions the European Union on Italian compulsory licenses
On 25 October 2011, the WTO TRIPS Council held its annual review of the Paragraph 6 System under Item G. Under the sub-heading of alternatives to the Paragraph 6 system, Ecuador asked the European Union (EU) about the issuance of three compulsory licenses in Italy between 2005 to 2007. In its intervention, Ecuador asked the EU for more detail regarding the Italian Competition Authority’s issuance of compulsory licenses for export to Spain and other EU members in cases involving Glaxo and Merck including, but not limited to, administrative procedures, decision-making processes, and rationale. Continue Reading
WTO TRIPS Council: US intervention on ACTA
This is the intervention that the United States made on ACTA on 25 October 2011 during the WTO TRIPS Council discussions of “Enforcement of Intellectual Property Rights”.
O. ENFORCEMENT OF INTELLECTUAL PROPERTY RIGHTS (PARTY III OF THE TRIPS AGREEMENT)The United States thanks Japan for its opening remarks, with which we fully associate ourselves.
We appreciate this opportunity to share with colleagues from other WTO Members our views on the importance of enforcement and to provide some additional information on the ACTA.
WTO TRIPS Council: Canada’s intervention on Access to Medicines in context of Paragraph 6 and Bill C-393
OCTOBER TRIPS COUNCIL MEETING
October 24-25, 2011
Canada’s Intervention for Agenda Item G (Access to Medicines)Mr. Chairman, Canada welcomes this opportunity to discuss the implementation of the Paragraph 6 system and to share some thoughts on the issue of access to medicines.
US Copyright Office 17 priorities
Register of Copyrights Maria A. Pallante has made public the “priorities and special projects” of the US Copyright Office from October 2011 to October 2013. The ambitious work plan sets 17 priorities in the areas of copyright policy and administrative practices, and 10 special projects “to improve the quality and efficiency of the U.S. Copyright Office’s services.”
The 16 page document is available here
Comments should be sent to registerofcopyrights@copyright.govHere’s a quick outline:
3 Studies
Recent cancer drug prices
2010
April 29, 2010.
Brand name: Provenge
Generic name: Sipuleucel-T
Marketed by: Dendreon
Indication: therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.
FDA press release here.
US Price: $31,000 per infusion. A full course of treatment is three infusions over a one-month period, or $93k.
Continue ReadingUSPTO issued patents mentioning ritonavir in a patent claim
This note begins by looking at patents issued by the USPTO that specifically mention the term ritonavir in the patent claims, or mention the NIH contract that was used to fund the early development of the product. This includes 194 patents that cite ritonavir in the patent claims, and another 42 patents that cite the NIH contact that funded the early ritonavir work. We also provide quotes from an August 19, 2011 WIPO report on the patent landscape for ritonavir that found 805 patent families related to ritonavir.
KEI comments on the ITPC Letter to the Medicines Patent Pool Foundation and UNITAID
The following excerpts are from an exchange of messages on ip-health about a recent recent petition regarding the patent pool that has been posted to several public health email lists. Among the leaders in the petition are apparently ITPC and the New York based I-MAK. ITPC has a long history of advocating for the interests of persons living with HIV, and I-MAK has for many years sought to overcome patent barriers for access to medicines. A copy of the petition is here http://www.petitionbuzz.com/petitions/mppunitaid.
UNITAID 3rd Consultative Forum; Nineteen IP recommendations
On 4-5 October 2011, UNITAID held its third Consultative Forum giving stakeholders the opportunity to view UNITAID’s achievements to date as well as provide input on UNITAID’s activities moving forward. Attendees at the forum included civil society, NGOs, implementing partners, representatives from the pharmaceutical industry and private foundations, and governmental officials. Several of the presentations from the IP workshop as well as the recommendations from the IP workshop are attached below.
Tedmund Y. Wan
Ted is a Public Service Institute Research Fellow at Knowledge Ecology International. He is a recent graduate of the University of Notre Dame Law School. During his law school career, he interned at a variety of public service and public policy organizations, including the United States Navy JAG, the Department of Justice, and Opportunity Maine, a grassroot advocacy organization.